| Medical and Health Sciences | Lifetime | 608 | ES 4 | 99.97 |
| Medical and Health Sciences | 2021-2025 | 147 | ES 6 | 99.97 |
| Cardiology and Cardiovascular Medicine | Lifetime | 76 | ES 1 | 99.93 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 268 | ES 2 | 99.34 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 14 | ES 1 | 99.93 |
| Surgery | 2021-2025 | 206 | ES 1 | 98.78 |
| Epidemiology | 2021-2025 | 243 | ES 8 | 98.18 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 136 | ES 2 | 97.38 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 667 | ES 11 | 91.82 |
| Cardiac Valve Diseases and Treatments | Lifetime | 20 | ES 1 | 99.94 |
| Cardiac Structural Anomalies and Repair | Lifetime | 17 | ES 1 | 99.87 |
| Cardiovascular Function and Risk Factors | Lifetime | 34 | ES 1 | 99.92 |
| Cardiac Imaging and Diagnostics | Lifetime | 50 | ES 1 | 99.89 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 25 | ES 1 | 99.87 |
| Cardiac Arrhythmias and Treatments | Lifetime | 79 | ES 3 | 99.69 |
| Cardiac pacing and defibrillation studies | Lifetime | 56 | ES 2 | 99.76 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 323 | ES 6 | 99.16 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 295 | ES 2 | 98.46 |
| Aortic Disease and Treatment Approaches | Lifetime | 320 | ES 3 | 98.58 |
| Cardiomyopathy and Myosin Studies | Lifetime | 370 | ES 4 | 97.92 |
| Cardiovascular Disease and Adiposity | Lifetime | 421 | ES 10 | 97.85 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 774 | ES 15 | 98.21 |
| Acute Myocardial Infarction Research | Lifetime | 825 | ES 29 | 97.60 |
| Cardiovascular Effects of Exercise | Lifetime | 856 | ES 16 | 95.73 |
| Pericarditis and Cardiac Tamponade | Lifetime | 898 | ES 30 | 83.69 |
| Aortic Thrombus and Embolism | Lifetime | 671 | ES 15 | 68.12 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 11 | ES 1 | 99.92 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 10 | ES 1 | 99.76 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 23 | ES 1 | 99.71 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 24 | ES 2 | 99.86 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 25 | ES 1 | 99.64 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 131 | ES 1 | 98.82 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 201 | ES 4 | 98.27 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 192 | ES 5 | 95.64 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 428 | ES 11 | 95.33 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 453 | ES 8 | 92.73 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 378 | ES 12 | 89.15 |
| Acute Myocardial Infarction Research | 2021-2025 | 644 | ES 20 | 92.75 |
| Congenital Heart Disease Studies | 2021-2025 | 793 | ES 5 | 89.41 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 589 | ES 19 | 88.21 |
